Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
472.90    -1.80 (-0.38%)
Bid:
472.50
Ask:
472.90
Spread: 0.40 (0.085%)
Market Cap: £5.89b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Ongoing incident at Garden Grove facility

26 May 2026 07:09

RNS Number : 6821F
Melrose Industries PLC
26 May 2026
 

26 May 2026

 

MELROSE INDUSTRIES PLC

 

Ongoing incident at Garden Grove facility in California

 

On Thursday 21 May, a thermal issue was identified regarding a storage tank containing methyl methacrylate (MMA) at GKN Aerospace's (GKN) Garden Grove facility in the US. MMA is a chemical used in the manufacture of high-strength aerospace acrylic materials. Action was taken immediately by GKN employees and emergency services notified.

 

As conditions evolved through Friday 22 May, the Orange County Fire Authority (OCFA) made the precautionary decision to issue mandatory evacuation orders for portions of the surrounding community to protect public safety while response operations continued.

Since then, technical specialists, the emergency services and the relevant authorities have continued to work closely to resolve the situation, with a focus on ensuring the safety of the local community, employees and everyone else involved.

 

As a result of the positive progress that has been made over the last few days and the reduced risk, on 25 May, the OCFA announced that the mandatory evacuation area had been significantly reduced with immediate effect.

 

At 6pm local time on 25 May, the local authorities confirmed that no injuries, leaks or contamination have occurred. GKN is working closely with customers on operational recovery and supply plans.

 

The progress made over the last few days is testament to the continued skill and dedication of all the support teams and services involved.

 

Further announcements will be issued as appropriate.

 

 

Enquiries:

 

Investor Relations:

 

Mat Wootton

 

+44 (0) 7483 961 233

mat.wootton@melroseplc.net

 

Media:

Simon Sporborg, Tom Pigott / Brunswick:

+44 (0) 207 404 5959

melrose@brunswickgroup.com

 

 

 

 

 

About Garden Grove

 

The Garden Grove facility in California, operated by GKN Aerospace Transparency Systems, Inc., designs, manufactures and provides aftermarket support for advanced military and commercial transparencies employing around 500 people. For financial year 2025, sales generated by the site were £136 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAKSKAEKKEEA
Date   Source Headline
4th Mar 20263:19 pmRNSNotification of Transactions of PDMR
4th Mar 20267:00 amRNSNotification of Transactions of PDMR
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 202610:39 amRNSTR-1: Standard Form-Notification of Major Holdings
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:12 amRNSDirector Declaration - 2nd March 2026
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSFINAL RESULTS
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20268:00 amRNSCFO succession
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:42 amRNSStandard form for notification of major holdings
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20265:42 pmRNSTR-1: Standard Form-Notification of Major Holdings
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20265:01 pmRNSTR-1: Standard Form-Notification of Major Holdings
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20263:00 pmRNSMary Petryszyn appointed as Non-Executive Director
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:35 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.